Advertisement

Topics

Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi Tanabe, Shionogi and Romark

02:00 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company, announces that its Idis Global Access (‘Idis GA’) division, has signed three further exclusive agreements to ...

Other Sources for this Article

Clinigen Group plc
Shaun Chilton, Group Chief Executive Officer
Steve Glass, Chief Commercial Officer
(North America and Europe)
Tel: +44 (0) 1283 495 010
or
Instinctif Partners
Melanie Toyne-Sewell / Alex Shaw
Email: clinigen@instinctif.com
Tel: +44 (0) 20 7457 2020

NEXT ARTICLE

More From BioPortfolio on "Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi Tanabe, Shionogi and Romark"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...